September 4, 2015

 Published by ECOMNEWS on September 1st, 2015   Publihed by BIOTECHFINANCES on September 4th, 2015   Published by on September 7th, 2015

April 2015

Review in Languedoc-Roussillon Magazine, L’accent du Sud, N°38, p9” on Medical Research: “Nanoparticles to fight cancer”.

December 8, 2014

Increase of capital funding of NanoMedSyn for internal R &D in lysosomal diseases and cancer.

April 8, 2014

NanoMedSyn signs a 3-year cooperative grant in the program «Program Nanotechnologies and Nanosystems (P2N)”, with Agence Nationale de la Recherche: “BIOSIPHARM: Biosafety of mesoporous silica nanoparticles according to their surface coverage and establishing standards for evaluation”. Partners: Institute Charles Gerhardt, CNRS UMR 5253, directed by Pr Jean-Marie Devoisselle, Montpellier 34, and IBEB/SBTN, directed of Dr

November, 2013

NanoMedSyn s’implique dans l’organisation du congrès international RARE 2013. RARE 2013 offre l’opportunité exceptionnelle de pouvoir rencontrer en un même lieu tous les acteurs du domaine des maladies rares afin de développer ensemble les médicaments de demain. Retrouver la vidéo de NanoMedSyn faite à l’occasion de ce congrès.

February 3, 2013

NanoMedSyn signs a 2-year cooperative grant in the program « Partner Research and Therapeutic Innovation (RPIB)”, with Agence Nationale de la Recherche: “LYSOPROD: Neoglycoenzyme for the therapy of lysosomal disease”. Partners: IBMM UMR 5247, Pr A. Morère, CNRS UPS 3044 laboratory directed by Dr Martine Cérutti, St Christol (30), and INSERM U845 Dr Catherine Caillaud,

Next Page →